231 related articles for article (PubMed ID: 28528775)
21. Bioactivity of the putative apelin proprotein expands the repertoire of apelin receptor ligands.
Shin K; Chapman NA; Sarker M; Kenward C; Huang SK; Weatherbee-Martin N; Pandey A; Dupré DJ; Rainey JK
Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):1901-1912. PubMed ID: 28546009
[TBL] [Abstract][Full Text] [Related]
22. Structure-Activity Relationship and Bioactivity of Short Analogues of ELABELA as Agonists of the Apelin Receptor.
Trân K; Murza A; Sainsily X; Delile E; Couvineau P; Côté J; Coquerel D; Peloquin M; Auger-Messier M; Bouvier M; Lesur O; Sarret P; Marsault É
J Med Chem; 2021 Jan; 64(1):602-615. PubMed ID: 33350824
[TBL] [Abstract][Full Text] [Related]
23. Apelinergic System Structure and Function.
Shin K; Kenward C; Rainey JK
Compr Physiol; 2017 Dec; 8(1):407-450. PubMed ID: 29357134
[TBL] [Abstract][Full Text] [Related]
24. [Functional dissociation between apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure].
Iturrioz X; El Messari S; De Mota N; Fassot C; Alvear-Perez R; Maigret B; Llorens-Cortes C
Arch Mal Coeur Vaiss; 2007 Aug; 100(8):704-8. PubMed ID: 17928781
[TBL] [Abstract][Full Text] [Related]
25. Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ.
Fan X; Zhou N; Zhang X; Mukhtar M; Lu Z; Fang J; DuBois GC; Pomerantz RJ
Biochemistry; 2003 Sep; 42(34):10163-8. PubMed ID: 12939143
[TBL] [Abstract][Full Text] [Related]
26. Identification of potent pyrazole based APELIN receptor (APJ) agonists.
Narayanan S; Vasukuttan V; Rajagopal S; Maitra R; Runyon SP
Bioorg Med Chem; 2020 Feb; 28(4):115237. PubMed ID: 31948845
[TBL] [Abstract][Full Text] [Related]
27. Complex with a phage display-derived peptide provides insight into the function of insulin-like growth factor I.
Schaffer ML; Deshayes K; Nakamura G; Sidhu S; Skelton NJ
Biochemistry; 2003 Aug; 42(31):9324-34. PubMed ID: 12899619
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationship of novel macrocyclic biased apelin receptor agonists.
Murza A; Sainsily X; Côté J; Bruneau-Cossette L; Besserer-Offroy É; Longpré JM; Leduc R; Dumaine R; Lesur O; Auger-Messier M; Sarret P; Marsault É
Org Biomol Chem; 2017 Jan; 15(2):449-458. PubMed ID: 27924341
[TBL] [Abstract][Full Text] [Related]
29. Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure.
El Messari S; Iturrioz X; Fassot C; De Mota N; Roesch D; Llorens-Cortes C
J Neurochem; 2004 Sep; 90(6):1290-301. PubMed ID: 15341513
[TBL] [Abstract][Full Text] [Related]
30. Structure-based design of non-hypertrophic apelin receptor modulator.
Wang WW; Ji SY; Zhang W; Zhang J; Cai C; Hu R; Zang SK; Miao L; Xu H; Chen LN; Yang Z; Guo J; Qin J; Shen DD; Liang P; Zhang Y; Zhang Y
Cell; 2024 Mar; 187(6):1460-1475.e20. PubMed ID: 38428423
[TBL] [Abstract][Full Text] [Related]
31. Targeting Apelinergic System in Cardiometabolic Disease.
Guo R; Rogers O; Nair S
Curr Drug Targets; 2017; 18(15):1785-1791. PubMed ID: 27296311
[TBL] [Abstract][Full Text] [Related]
32. Rational design of type-IA receptor-derived cyclic peptides to target human bone morphogenic protein 2.
Fan X; Xia H; Liu X; Li B; Fang J
J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894111
[TBL] [Abstract][Full Text] [Related]
33. Elabela and Apelin actions in healthy and pathological pregnancies.
Eberlé D; Marousez L; Hanssens S; Knauf C; Breton C; Deruelle P; Lesage J
Cytokine Growth Factor Rev; 2019 Apr; 46():45-53. PubMed ID: 30910349
[TBL] [Abstract][Full Text] [Related]
34. An Expedient Synthesis of CMF-019: (S)-5-Methyl-3-{1-(pentan-3-yl)-2- (thiophen-2-ylmethyl)-1H-benzo[d]imidazole-5-carboxamido}hexanoic Acid, a Potent Apelin Receptor (APJ) Agonist.
Trifonov L; Afri M; Palczewski K; Korshin EE; Gruzman A
Med Chem; 2018; 14(7):688-694. PubMed ID: 29651942
[TBL] [Abstract][Full Text] [Related]
35. The effects of water immersion and restraint stress on the expressions of apelin, apelin receptor (APJR) and apoptosis rate in the rat heart.
Ustunel I; Acar N; Gemici B; Ozbey O; Edizer I; Soylu H; Tepekoy F; Izgut-Uysal VN
Acta Histochem; 2014 Jun; 116(5):675-81. PubMed ID: 24411164
[TBL] [Abstract][Full Text] [Related]
36. Toward parathyroid hormone minimization: conformational studies of cyclic PTH(1-14) analogues.
Tsomaia N; Pellegrini M; Hyde K; Gardella TJ; Mierke DF
Biochemistry; 2004 Jan; 43(3):690-9. PubMed ID: 14730973
[TBL] [Abstract][Full Text] [Related]
37. Expanding the apelin receptor pharmacological toolbox using novel fluorescent ligands.
Williams TL; Macrae RGC; Kuc RE; Brown AJH; Maguire JJ; Davenport AP
Front Endocrinol (Lausanne); 2023; 14():1139121. PubMed ID: 36967803
[TBL] [Abstract][Full Text] [Related]
38. Apelin Receptor Signaling During Mesoderm Development.
Sağraç D; Şişli HB; Doğan A
Adv Exp Med Biol; 2020; 1298():1-15. PubMed ID: 32648246
[TBL] [Abstract][Full Text] [Related]
39. Structural insight into G-protein coupled receptor binding by apelin.
Langelaan DN; Bebbington EM; Reddy T; Rainey JK
Biochemistry; 2009 Jan; 48(3):537-48. PubMed ID: 19123778
[TBL] [Abstract][Full Text] [Related]
40. Signal transduction mechanism of a peptide mimetic of interferon-gamma.
Subramaniam PS; Flowers LO; Haider SM; Johnson HM
Biochemistry; 2004 May; 43(18):5445-54. PubMed ID: 15122910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
